Stock Market Today, June: AbbVie Cash Offer Boosts Apogee
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articlesA major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Marvell Technology has staged a decisive run in 2026, outpacing Broadcom in the AI accelerator stock race. As data-ce...
Retirement isn’t just about money—it’s about meaning. Discover how to win the retirement game: connect socially with ...
Apple sticks to an asset-light model with robust buybacks, while Microsoft escalates capital spending to fuel AI and ...
Stryker and Intuitive Surgical reported divergent Q1 2026 results, underscoring two distinct medtech playbooks. Stryk...
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...
Fresh data suggests U.S. home prices may have found a floor. As affordability stabilizes, demand returns and lenders ...
Honeywell’s recent spin-offs split the company into four standalone names. This guide breaks down each stock, explain...
Starbucks is building in-house AI tools to reduce its reliance on Microsoft and IBM software, aiming to cut costs and...
Google and Apple are leading the AI stock surge. This piece weighs valuation, growth, and cash flow to answer which m...
A little-known corner of the market, rare earth stocks have moved in big swings. Here's how USA Rare Earth powered an...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...